Market Research Logo

CytoSorbents Corporation (CTSO) - Product Pipeline Analysis, 2016 Update

Summary

CytoSorbents Corporation (CytoSorbents), formerly MedaSorb Technologies Corporation is a medical device company that designs and develops blood purification technology. The company develops adsorbent polymer technology to provide blood purification for acute and chronic health complications associated with blood toxicity. Its technologies include betasorb, hemodefend and cytosorb. The company’s hemodefend is a development-stage blood purification technology platform for the blood transfusion industry that is aimed to reduce transfusion reactions and safeguard the quality and safety of blood products. CytoSorbents is headquartered in Monmouth Junction, New Jersey, the US.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

  • The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
  • The report analyzes all pipeline products in development for the company CytoSorbents Corporation
  • The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
  • The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
  • The report provides detailed description of products in development, technical specification and functions
  • The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to Buy:
  • Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
  • Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
  • To formulate effective Research & Development strategies
  • Develop market-entry and market expansion strategies
  • Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
  • Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
  • Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio


CytoSorbents Corporation Company Snapshot
CytoSorbents Corporation Company Overview
CytoSorbents Corporation Pipeline Products and Clinical Trials Overview
CytoSorbents Corporation – Pipeline Analysis Overview
Key Facts
CytoSorbents Corporation - Major Products and Services
CytoSorbents Corporation Pipeline Products by Development Stage
CytoSorbents Corporation Clinical Trials by Trial Status
CytoSorbents Corporation Pipeline Products Overview
BetaSorb
BetaSorb Product Overview
ContrastSorb
ContrastSorb Product Overview
CST 301
CST 301 Product Overview
CytoSorb
CytoSorb Product Overview
CytoSorb Clinical Trial
CytoSorb - Cardiac Surgery And Organ Preservation
CytoSorb - Cardiac Surgery And Organ Preservation Product Overview
DrugSorb
DrugSorb Product Overview
HemoDefend
HemoDefend Product Overview
CytoSorbents Corporation - Key Competitors
CytoSorbents Corporation - Key Employees
CytoSorbents Corporation - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Recent Developments
CytoSorbents Corporation, Recent Developments
Jul 13, 2016: CytoSorbents Teams with Medial and Meditrade to Bring CytoSorb to Hungary, Czech Republic, Slovakia, and Poland
Jun 22, 2016: CytoSorbents Awarded $150,000 Phase I STTR Contract for Universal Plasma Development
Jun 13, 2016: CytoSorbents and Palex Bring CytoSorb to Spain and Portugal
Jun 01, 2016: CytoSorbents Announces Fresenius Medical Care Initiates Sales of CytoSorb in France, Poland and Scandinavia
May 27, 2016: Independent Data Safety Monitoring Board Recommends Continuation of CytoSorbents REFRESH I Trial
May 18, 2016: CytoSorb Achieves Final Product Registration in Russia
May 09, 2016: CytoSorbents Continues Strong Growth in Q1 2016
May 06, 2016: CytoSorbents Establishes Swiss Subsidiary
Mar 25, 2016: CytoSorbents Awarded $150,000 Phase I SBIR Contract for Fungal Mycotoxin Removal
Mar 16, 2016: CytoSorbents Reports on Successful 3rd International CytoSorb Users Meeting
Appendix
Methodology
About GlobalData
Contact Us
Disclaimer
List of Tables
CytoSorbents Corporation Pipeline Products and Clinical Trials Overview
CytoSorbents Corporation Pipeline Products by Equipment Type
CytoSorbents Corporation Pipeline Products by Indication
CytoSorbents Corporation Clinical Trials by Trial Status
CytoSorbents Corporation, Key Facts
CytoSorbents Corporation, Major Products and Services
CytoSorbents Corporation Number of Pipeline Products by Development Stage
CytoSorbents Corporation Pipeline Products Summary by Development Stage
CytoSorbents Corporation Clinical Trials by Trial Status
CytoSorbents Corporation Clinical Trials Summary
BetaSorb - Product Status
BetaSorb - Product Description
ContrastSorb - Product Status
ContrastSorb - Product Description
CST 301 - Product Status
CST 301 - Product Description
CytoSorb - Product Status
CytoSorb - Product Description
CytoSorb - Case-observation and Compassionate Use: Use of Extracorporeal Treatment with the Cytosorb-Adsorber for the Reduction of Postoperative Hyperinflammation and SIRS After Heart-surgery with the Use of a Heart-lung-machine
CytoSorb - Cytokine Adsorption in Sepsis and Acute Kidney Injury
CytoSorb - Cytokine Clearance with Cytoabsorbant Device During Cardiac Bypass: A Pilot Study
CytoSorb - CytoSorb Reduction of Free Hemoglobin During Cardiac Surgery
CytoSorb - Efficacy Study of CytoSorb in Reducing Myoglobin Levels in Human Trauma Patients with Rhabdomyolysis
CytoSorb - Extracorporeal Elimination of Cytokines Following Abdominal-thoracic Esophagectomy - A Randomized Study (EXCESS)
CytoSorb - Extracorporeal Therapy for the Removal of Myoglobin Using the CytoSorb in Patients with Rhabdomyolysis
CytoSorb - Immunomodulatory Effect of Extracorporeal Cytokine Adsorption in Cardiac Surgery
CytoSorb - International Registry on the Use of the CytoSorb-Adsorber in ICU Patients
CytoSorb - Removal of Cytokine on Cardiopulmonary Bypass with CytoSorb Compared to on- and Off-pump Myocardial Revascularization
CytoSorb - The Effect of Early Cytokine Absorption on the Systemic Inflammatory Response Syndrome and Organ Dysfunction in the First 48 Hours of Septic Shock
CytoSorb - Cardiac Surgery And Organ Preservation - Product Status
CytoSorb - Cardiac Surgery And Organ Preservation - Product Description
DrugSorb - Product Status
DrugSorb - Product Description
HemoDefend - Product Status
HemoDefend - Product Description
CytoSorbents Corporation, Key Employees
CytoSorbents Corporation, Subsidiaries
List of Figures
CytoSorbents Corporation Pipeline Products by Equipment Type
CytoSorbents Corporation Pipeline Products by Development Stage
CytoSorbents Corporation Clinical Trials by Trial Status

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report